TP53 and gastric carcinoma: It has been demonstrated that the restoration of miR34A expression can inhibit the growth of TP53-mutant gastric carcinoma cells [54], and that miR34A mimics inhibit the growth of DLBCL and pulmonary carcinoma in in vivo mouse models [38, 55].